Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics

The SARS-CoV-2 virus needs multiple copies for its multiplication using an enzyme RNA-dependent RNA polymerase (RdRp). Remdesivir inhibits viral RdRp, controls the multiplication of the virus, and protects patients. However, treatment of COVID-19 with remdesivir involves adverse effects. Many ongoin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bhaswati Chatterjee, Suman S. Thakur
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2022-05-01
Colecção:Frontiers in Immunology
Assuntos:
repurposed drugs
therapeutics
COVID-19
remdesivir
baricitinib
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2022.830990/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados